XBI

SPDR S&P Biotech ETF

Up$85.74
+$1.65
(+1.96%)
As of 1:00:00 AM EDT | 2/22/19  |  Market Closed

XBI Trading Data

Open

$84.5

Low Price

$83.99

High Price

$85.88

Previous Last Price

$84.09

Bid Size

$0 X 0

Ask Size

$0 X 0

XBI Portfolio Data

AUM

$4,017,112,000

Shares

47,800

PE Ratio

17.32

Price / Book Ratio

4.4

Expense Ratio

0.35

Net Asset Value

$84.04

Volume

Volume

3,407,800

Avg. Volume (YDT)

4,591,086

Dollar Volume

$257,190,027

Weekly Avg. Volume

4,233,180

Monthly Avg. Volume

3,660,870

Quarterly Avg. Volume

5,604,344

XBI Fund Description

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

XBI Chart

XBI Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Biotech ETF

Inception Date

2006-01-31

Asset Class

Equity

Asset Class Size

Biotech

XBI Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XBI Holdings

Top 10 Holdings

Mirati Therapeutics Inc. (MRTX)
2.12%
Portola Pharmaceuticals Inc. (PTLA)
1.94%
SAGE Therapeutics Inc. (SAGE)
1.81%
Array BioPharma Inc. (ARRY)
1.79%
Celgene Corporation (CELG)
1.64%
FibroGen Inc. (FGEN)
1.61%
Ultragenyx Pharmaceutical Inc. (RARE)
1.6%
ACADIA Pharmaceuticals Inc. (ACAD)
1.59%
Incyte Corporation (INCY)
1.59%
bluebird bio Inc. (BLUE)
1.55%

Total XBI Holdings

Total Holdings: 121

Mirati Therapeutics Inc. (MRTX)
2.12%
Portola Pharmaceuticals Inc. (PTLA)
1.94%
SAGE Therapeutics Inc. (SAGE)
1.81%
Array BioPharma Inc. (ARRY)
1.79%
Celgene Corporation (CELG)
1.64%
FibroGen Inc. (FGEN)
1.61%
Ultragenyx Pharmaceutical Inc. (RARE)
1.6%
ACADIA Pharmaceuticals Inc. (ACAD)
1.59%
Incyte Corporation (INCY)
1.59%
bluebird bio Inc. (BLUE)
1.55%
Exact Sciences Corporation (EXAS)
1.54%
Global Blood Therapeutics Inc (GBT)
1.49%
Spark Therapeutics Inc. (ONCE)
1.49%
Alexion Pharmaceuticals Inc. (ALXN)
1.47%
Clovis Oncology Inc. (CLVS)
1.47%
Puma Biotechnology Inc. (PBYI)
1.46%
Seattle Genetics Inc. (SGEN)
1.44%
Arrowhead Pharmaceuticals Inc. (ARWR)
1.44%
Sarepta Therapeutics Inc. (SRPT)
1.44%
Madrigal Pharmaceuticals Inc. (MDGL)
1.44%
Heron Therapeutics Inc (HRTX)
1.41%
Regeneron Pharmaceuticals Inc. (REGN)
1.38%
Agios Pharmaceuticals Inc. (AGIO)
1.37%
United Therapeutics Corporation (UTHR)
1.37%
Ionis Pharmaceuticals Inc. (IONS)
1.37%
Neurocrine Biosciences Inc. (NBIX)
1.37%
Vertex Pharmaceuticals Incorporated (VRTX)
1.36%
Amicus Therapeutics Inc. (FOLD)
1.35%
Biogen Inc. (BIIB)
1.28%
Myriad Genetics Inc. (MYGN)
1.28%
Exelixis Inc. (EXEL)
1.27%
Blueprint Medicines Corp. (BPMC)
1.27%
Arena Pharmaceuticals Inc. (ARNA)
1.26%
Gilead Sciences Inc. (GILD)
1.26%
REGENXBIO Inc. (RGNX)
1.26%
Alnylam Pharmaceuticals Inc (ALNY)
1.25%
Alkermes Plc (ALKS)
1.25%
Enanta Pharmaceuticals Inc. (ENTA)
1.24%
Amgen Inc. (AMGN)
1.21%
Viking Therapeutics Inc. (VKTX)
1.2%
BioMarin Pharmaceutical Inc. (BMRN)
1.2%
AnaptysBio Inc. (ANAB)
1.17%
PTC Therapeutics Inc. (PTCT)
1.17%
Esperion Therapeutics Inc. (ESPR)
1.16%
AbbVie Inc. (ABBV)
1.16%
Insmed Incorporated (INSM)
1.15%
Genomic Health Inc. (GHDX)
1.12%
Repligen Corporation (RGEN)
1.1%
Emergent BioSolutions Inc. (EBS)
1.09%
Ligand Pharmaceuticals Incorporated (LGND)
1.08%
Intercept Pharmaceuticals Inc. (ICPT)
1.07%
Invitae Corp. (NVTA)
1.01%
Immunomedics Inc. (IMMU)
0.96%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.92%
Spectrum Pharmaceuticals Inc. (SPPI)
0.91%
Atara Biotherapeutics Inc (ATRA)
0.84%
CareDx Inc. (CDNA)
0.84%
Sangamo Therapeutics Inc. (SGMO)
0.83%
Acceleron Pharma Inc (XLRN)
0.73%
ImmunoGen Inc. (IMGN)
0.73%
Halozyme Therapeutics Inc. (HALO)
0.68%
Radius Health Inc (RDUS)
0.67%
Intrexon Corporation (XON)
0.64%
Aimmune Therapeutics Inc (AIMT)
0.63%
Coherus BioSciences Inc. (CHRS)
0.63%
OPKO Health Inc. (OPK)
0.62%
Natera Inc. (NTRA)
0.62%
Iovance Biotherapeutics Inc (IOVA)
0.62%
Cara Therapeutics Inc (CARA)
0.62%
Audentes Therapeutics Inc. (BOLD)
0.62%
Editas Medicine Inc. (EDIT)
0.62%
Eagle Pharmaceuticals Inc. (EGRX)
0.6%
Alder Biopharmaceuticals Inc. (ALDR)
0.59%
Verastem Inc. (VSTM)
0.58%
Vericel Corporation (VCEL)
0.58%
AMAG Pharmaceuticals Inc. (AMAG)
0.54%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
0.53%
Flexion Therapeutics Inc. (FLXN)
0.53%
Momenta Pharmaceuticals Inc. (MNTA)
0.52%
Acorda Therapeutics Inc. (ACOR)
0.51%
Intellia Therapeutics Inc. (NTLA)
0.51%
Vanda Pharmaceuticals Inc. (VNDA)
0.5%
Dynavax Technologies Corporation (DVAX)
0.46%
Epizyme Inc. (EPZM)
0.45%
Xencor Inc. (XNCR)
0.39%
G1 Therapeutics Inc. (GTHX)
0.39%
TG Therapeutics Inc. (TGTX)
0.36%
Progenics Pharmaceuticals Inc. (PGNX)
0.34%
Karyopharm Therapeutics Inc. (KPTI)
0.34%
Novavax Inc. (NVAX)
0.34%
Retrophin Inc. (RTRX)
0.33%
Fate Therapeutics Inc. (FATE)
0.33%
MacroGenics Inc. (MGNX)
0.32%
CytomX Therapeutics Inc. (CTMX)
0.3%
Dicerna Pharmaceuticals Inc. (DRNA)
0.3%
Denali Therapeutics Inc. (DNLI)
0.3%
Deciphera Pharmaceuticals Inc. (DCPH)
0.28%
Rigel Pharmaceuticals Inc. (RIGL)
0.26%
Prothena Corp. Plc (PRTA)
0.25%
ArQule Inc. (ARQL)
0.22%
Sorrento Therapeutics Inc. (SRNE)
0.22%
PDL BioPharma Inc. (PDLI)
0.21%
Five Prime Therapeutics Inc. (FPRX)
0.18%
GlycoMimetics Inc. (GLYC)
0.18%
BioCryst Pharmaceuticals Inc. (BCRX)
0.18%
ZIOPHARM Oncology Inc. (ZIOP)
0.18%
Athenex Inc. (ATNX)
0.17%
Allakos Inc. (ALLK)
0.17%
Inovio Pharmaceuticals Inc. (INO)
0.16%
Akebia Therapeutics Inc. (AKBA)
0.16%
Rhythm Pharmaceuticals Inc. (RYTM)
0.16%
Achillion Pharmaceuticals Inc. (ACHN)
0.15%
Stemline Therapeutics Inc. (STML)
0.15%
Kura Oncology Inc. (KURA)
0.14%
Apellis Pharmaceuticals Inc. (APLS)
0.13%
Lexicon Pharmaceuticals Inc. (LXRX)
0.11%
Solid Biosciences Inc. (SLDB)
0.11%
Cytokinetics Incorporated (CYTK)
0.09%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.04%
SPDR S & P Biotech ETF (XBI)
0%
U.S. Dollar
0%

XBI Technicals

Alpha

-8

Beta

1.65

Leverage

Long

Standard Deviation

8.58

XBI Dividends

Dividend Date

2018-12-21

Latest Dividend

0.012

Annual Dividend

0.2

Annual Dividend Rate

0.2

Annual Dividend Yield

0.24

XBI Performance

YTD Return

19.5%

1 Year Return

-5.96%

3 Year Return

73.56%

5 Year Return

57.11%

10 Year Return

455.79%

XBI Related Articles

Biotech ETFs Could See More Inflows

Biotech ETFs Could See More Inflows

After languishing in the latter stages of 2018, the iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech exchange traded fund…